4584.T
Kidswell Bio Corporation
グロース · 医薬品 · 医薬品 · JP
JPY 161.00
−3.59%Aug 14, 2026, 07:33 UTC
Kids Well Bio announced that its subsidiary S-Quatre, in collaboration with Nagoya University, completed a clinical study on cerebral palsy treatment using stem cells derived from baby teeth, with an independent safety evaluation committee confirming safety throughout the observation period.
Source:Aug 13, 2026, 07:00 UTC
Kids Well Bio announced its first-quarter results for April-June 2026, with consolidated ordinary profit rising 16.0% year-on-year to 200 million yen.
Source: